AureoGen Announces Licensing Agreement with Merck
February 24, 2016 at 10:05 AM EST
AureoGen Biosciences Inc. today announced a licensing agreement with Merck, (NYSE: MRK), for the use of AureoGen's proprietary ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.